[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 100620
1. Williams DA: Of Mouse Models and Men. Mol Ther; 2007 Apr;15(4):643

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Of Mouse Models and Men.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28192701.001).
  • [ISSN] 1525-0024
  • [Journal-full-title] Molecular therapy : the journal of the American Society of Gene Therapy
  • [ISO-abbreviation] Mol. Ther.
  • [Language] eng
  • [Publication-type] Editorial
  • [Publication-country] United States
  •  go-up   go-down


2. Hobley J, Lengerich EJ, Lindsay Ii JA, McGarrity TJ: Disparities Between Blacks and Whites in Stage at Diagnosis, Incidence, and Anatomic Subsite of Colorectal Cancer. Gastroenterol Hepatol (N Y); 2006 Jul;2(7):498-502

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Disparities Between Blacks and Whites in Stage at Diagnosis, Incidence, and Anatomic Subsite of Colorectal Cancer.
  • <b><i>Background</i></b> A disparity in colorectal cancer (CRC) incidence and mortality has been reported for black men and women in the United States.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Natl Cancer Inst. 2005 Nov 16;97(22):1679-87 [16288121.001]
  • [Cites] Int J Cancer. 2002 Oct 10;101(5):403-8 [12216066.001]
  • [Cites] CA Cancer J Clin. 2001 Jan-Feb;51(1):38-75; quiz 77-80 [11577479.001]
  • [Cites] Cancer. 1997 Jul 15;80(2):193-7 [9217029.001]
  • [Cites] Cancer Causes Control. 1999 Dec;10(6):525-37 [10616822.001]
  • [Cites] Cancer. 2001 Nov 15;92(10):2547-54 [11745188.001]
  • [Cites] J Rural Health. 2005 Winter;21(1):39-47 [15667008.001]
  • [Cites] Gastroenterology. 2004 Dec;127(6):1678-84 [15578504.001]
  • [Cites] Clin Colorectal Cancer. 2004 Feb;3(4):243-7 [15025797.001]
  • [Cites] Cancer. 1997 Feb 1;79(3):441-7 [9028352.001]
  • [Cites] World J Gastroenterol. 2003 Apr;9(4):721-5 [12679919.001]
  • [Cites] Am Surg. 2001 Dec;67(12):1157-61 [11768820.001]
  • [Cites] Med Care. 2002 Aug;40(8 Suppl):IV-104-17 [12187175.001]
  • [Cites] Int J Cancer. 1997 Dec 19;74(6):664-9 [9421366.001]
  • [Cites] J Assoc Acad Minor Phys. 1999;10(3):51-8 [10826010.001]
  • [Cites] Dig Dis Sci. 2002 Dec;47(12):2715-9 [12498291.001]
  • (PMID = 28289352.001).
  • [ISSN] 1554-7914
  • [Journal-full-title] Gastroenterology & hepatology
  • [ISO-abbreviation] Gastroenterol Hepatol (N Y)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Disparity / colorectal cancer / morbidity / mortality
  •  go-up   go-down


3. Sauk J, Jensen DM, Mohanty SR, Reau N, Reddy KG, Te HS: Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis. Gastroenterol Hepatol (N Y); 2006 Jul;2(7):504-508

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis.
  • Demographic and laboratory data were obtained from medical records.
  • <b><i>Results</i></b> There were 7 men and 6 women, with a mean age of 54±11 years; 11 patients (85%) were African American and 11 patients (85%) were infected with HCV genotype 1.
  • None of the 13 patients achieved sustained virologic response; 2 patients (15%) had an undetectable viral load at the end of therapy but relapsed within 6 months of follow-up.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Rom J Gastroenterol. 2004 Jun;13(2):99-102 [15229772.001]
  • [Cites] Curr Gastroenterol Rep. 2004 Feb;6(1):66-70 [14720456.001]
  • [Cites] Hepatology. 1999 Jan;29(1):257-63 [9862875.001]
  • [Cites] N Engl J Med. 1998 Nov 19;339(21):1485-92 [9819446.001]
  • [Cites] Nephrol Dial Transplant. 2005 May;20(5):991-3 [15741205.001]
  • [Cites] Aliment Pharmacol Ther. 2004 Jul 1;20(1):123-4; author reply 124 [15225179.001]
  • [Cites] J Hepatol. 1995 Jun;22(6):696-9 [7560864.001]
  • [Cites] Nephrol Dial Transplant. 2001 Jan;16(1):193-5 [11209032.001]
  • [Cites] J Clin Pharmacol. 2002 Oct;42(10 ):1109-15 [12362925.001]
  • [Cites] Lancet. 1998 Oct 31;352(9138):1426-32 [9807989.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Dec;18(11-12):1071-81 [14653826.001]
  • [Cites] Clin Nephrol. 2005 Mar;63(3):232-5 [15786827.001]
  • [Cites] Lancet. 2001 Sep 22;358(9286):958-65 [11583749.001]
  • [Cites] Hepatology. 2004 Jun;39(6):1702-8 [15185312.001]
  • [Cites] Nephrol Dial Transplant. 1996;11 Suppl 4:46-7 [8918753.001]
  • [Cites] J Am Soc Nephrol. 1998 Dec;9(12 ):2344-8 [9848789.001]
  • [Cites] N Engl J Med. 2001 Jul 5;345(1):41-52 [11439948.001]
  • [Cites] N Engl J Med. 2004 May 27;350(22):2265-71 [15163776.001]
  • [Cites] Am J Gastroenterol. 2003 Jul;98(7):1610-5 [12873587.001]
  • [Cites] Int J Artif Organs. 1990 Nov;13(11):737-41 [2128485.001]
  • [Cites] J Hepatol. 1999;31 Suppl 1:107-12 [10622571.001]
  • [Cites] Transplantation. 1998 Mar 15;65(5):667-70 [9521201.001]
  • [Cites] Am J Kidney Dis. 2005 Apr;45(4):684-9 [15806471.001]
  • [Cites] Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S113-7 [16234057.001]
  • [Cites] Am J Kidney Dis. 1993 Dec;22(6):822-8 [7504404.001]
  • [Cites] Transplant Proc. 1998 Aug;30(5):2070-2 [9723395.001]
  • [Cites] Semin Liver Dis. 2004;24 Suppl 2:69-77 [15346249.001]
  • [Cites] N Engl J Med. 2000 Dec 7;343 (23 ):1673-80 [11106716.001]
  • [Cites] Nephron. 1992;61(3):307-8 [1323776.001]
  • [Cites] Transplantation. 1991 Nov;52(5):810-3 [1949165.001]
  • [Cites] Am J Transplant. 2005 Jun;5(6):1452-61 [15888054.001]
  • [Cites] Am J Kidney Dis. 1998 Oct;32(4):629-34 [9774125.001]
  • [Cites] Clin Pharmacokinet. 1990 Nov;19(5):390-9 [1702693.001]
  • [Cites] Nephrol Dial Transplant. 1996;11 Suppl 4:48-51 [8918754.001]
  • [Cites] Hepatology. 2002 Jul;36(1):3-10 [12085342.001]
  • [Cites] J Am Soc Nephrol. 2000 Oct;11(10):1896-902 [11004221.001]
  • [Cites] Aliment Pharmacol Ther. 2004 Dec;20(11-12):1271-7 [15606388.001]
  • [Cites] Curr Opin Nephrol Hypertens. 1998 Sep;7(5):557-62 [9818204.001]
  • [Cites] Br J Clin Pharmacol. 1999 Apr;47(4):365-71 [10233199.001]
  • [Cites] N Engl J Med. 2000 Dec 7;343 (23 ):1666-72 [11106715.001]
  • [Cites] Nephrol Dial Transplant. 1996 Nov;11(11):2265-8 [8941588.001]
  • [Cites] Semin Dial. 2004 Jul-Aug;17(4):310-9 [15250925.001]
  • [Cites] Am J Transplant. 2001 Jul;1(2):179-84 [12099367.001]
  • [Cites] Clin Pharmacol Ther. 2000 Nov;68(5):556-67 [11103758.001]
  • [Cites] Nephron. 1998 Sep;80(1):51-6 [9730703.001]
  • [Cites] J Viral Hepat. 2001 Jul;8(4):287-92 [11454181.001]
  • [Cites] Clin Nephrol. 1992 Jul;38(1):44-8 [1499168.001]
  • (PMID = 28289353.001).
  • [ISSN] 1554-7914
  • [Journal-full-title] Gastroenterology & hepatology
  • [ISO-abbreviation] Gastroenterol Hepatol (N Y)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Hepatitis C / dialysis / end-stage / pegylated interferon / renal disease / renal failure
  •  go-up   go-down


Advertisement
4. Shaya FT, Gu A, Saunders E: Metabolic Syndrome Prevalence in an Urban African American Population. Diabetes Metab Syndr; 2007 Sep;1(3):151-157

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metabolic Syndrome Prevalence in an Urban African American Population.
  • BACKGROUND: The metabolic syndrome (MeS) is a clustering of a group of metabolic risk factors in one person that predisposes to higher risk of cardiovascular disease (CVD) and type II diabetes.
  • The metabolic syndrome has become increasingly common in the United States.
  • With the increase in CVD morbidity and mortality among US adult populations, particularly African Americans, it becomes urgent to monitor and control metabolic syndrome in an effort to inform effective CVD prevention programs.
  • We sought to assess the prevalence of and predictors of MeS syndrome in an urban, high risk, predominantly African American hypertensive population.
  • Risk factors for metabolic syndrome were assessed at baseline, and include risk factors of abdominal obesity (BMI = 30), high triglycerides (triglycerides = 150 mg/dL), low HDL cholesterol (HDL < 40 mg/dL in men, or HDL <50 mg/dL in women), elevated blood pressure (BP = 130/85 mmHg), and elevated fasting glucose (blood glucose = 100 mg/dL) - per ATP III criteria.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 2005 Apr 16-22;365(9468):1415-28 [15836891.001]
  • [Cites] Diabetes Care. 2004 Oct;27(10):2444-9 [15451914.001]
  • [Cites] J Natl Med Assoc. 2003 Jul;95(7):523-32 [12911249.001]
  • [Cites] Am J Psychiatry. 2003 Jul;160(7):1326-31 [12832249.001]
  • [Cites] JAMA. 2005 Jul 27;294(4):466-72 [16046653.001]
  • [Cites] JAMA. 2006 Jul 5;296(1):79-86 [16820550.001]
  • [Cites] Postgrad Med. 2002 Oct;112(4):24-6, 29-30, 33-4 passim [12405099.001]
  • [Cites] JAMA. 2002 Jan 16;287(3):356-9 [11790215.001]
  • [Cites] Ann Pharmacother. 2002 Jun;36(6):986-91 [12022897.001]
  • [Cites] Lancet. 2005 Apr 16-22;365(9468):1398-405 [15836888.001]
  • [Cites] Int J Obes Relat Metab Disord. 2002 Sep;26(9):1205-10 [12187397.001]
  • [Cites] J Natl Med Assoc. 2005 Dec;97(12):1630-8 [16396055.001]
  • [Cites] Am J Hypertens. 1997 Jul;10(7 Pt 1):697-704 [9234822.001]
  • [Cites] Lancet. 2002 Dec 14;360(9349):1903-13 [12493255.001]
  • [Cites] Endocrinol Metab Clin North Am. 2004 Jun;33(2):351-75, table of contents [15158523.001]
  • [Cites] Am J Med Sci. 2005 Dec;330(6):273-9 [16355011.001]
  • [Cites] Am J Health Behav. 2001 Mar-Apr;25(2):83-99 [11297045.001]
  • [Cites] Lancet. 2006 Jul 22;368(9532):261-2 [16860679.001]
  • (PMID = 28194239.001).
  • [ISSN] 1878-0334
  • [Journal-full-title] Diabetes & metabolic syndrome
  • [ISO-abbreviation] Diabetes Metab Syndr
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / M01 RR016500; United States / NHLBI NIH HHS / HL / U01 HL079151; United States / NHLBI NIH HHS / HL / U01 HL079151-01
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


5. Sabanathan S, Oomeer S, Jenkinson LR: Cholecystectomy or Cholelithiasis - a Missed Marker for Hyperlipidaemia? A Combined Retrospective and Prospective Study. Gastroenterology Res; 2008 Dec;1(1):29-32

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Multiple studies have shown an association between gallstones and abnormal lipids and the latter increases the risk of coronary artery disease and stroke.
  • Only 36.2% of women and 36.9% of men who had a cholecystectomy had a full lipid profile including high density lipoproteins (HDL) and low density lipoproteins (LDL).
  • Of these, 76.4% of women and 70.7% of men had an abnormal lipid profile.
  • In the prospective group, 91.1 % of women and 96.3 % of men had a full lipid profile.
  • These were abnormal in 81.4% of women and 70.4 % of men.
  • Current guidelines suggest they are at an increased risk of cardiovascular disease and should be treated.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27994703.001).
  • [ISSN] 1918-2805
  • [Journal-full-title] Gastroenterology research
  • [ISO-abbreviation] Gastroenterology Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Keywords] NOTNLM ; cholecystectomy / gallstones hypercholesterolaemia / hyperlipidaemia / hypertri-glyceridaemia
  •  go-up   go-down


6. Mason PK, Moorman L, Lake DE, Mangrum JM, DiMarco JP, Ferguson JD, Mahapatra S, Bilchick KC, Wiggins D, Mounsey JP, Moorman JR: Gender and Racial Characteristics of Patients Referred to a Tertiary Atrial Fibrillation Center. J Atr Fibrillation; 2010 Dec;3(4):301
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Twice as many men were referred as women (570 vs. 1094; P<0.0001).
  • Women were older (68.0±11.9 vs. 62.4±13.0 years; P<0.0001) and more symptomatic with palpitations (80% vs. 73%; P=0.008), but otherwise were not substantially different from men.
  • Our referring physicians treated the majority of both men and women with anticoagulant and rate-controlling medications.
  • In contrast, they accounted for 7.4% of patients seen for a primary diagnosis of AF at all other UVA outpatient clinics (P<0.0001).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Value Health. 2006 Sep-Oct;9(5):348-56 [16961553.001]
  • [Cites] Curr Opin Cardiol. 2010 Jan;25(1):8-15 [19940767.001]
  • [Cites] Heart Rhythm. 2007 Mar;4(3 Suppl):S1-6 [17336876.001]
  • [Cites] N Engl J Med. 1999 Feb 25;340(8):618-26 [10029647.001]
  • [Cites] J Med Ethics. 2006 Aug;32(8):435-8 [16877620.001]
  • [Cites] Am J Cardiol. 1990 May 1;65(16):1112-6 [2330896.001]
  • [Cites] N Engl J Med. 2002 Dec 5;347(23):1834-40 [12466507.001]
  • [Cites] Am Heart J. 2009 Jul;158(1):111-7 [19540400.001]
  • [Cites] J Am Coll Cardiol. 2007 Feb 6;49(5):572-7 [17276181.001]
  • [Cites] J Am Coll Cardiol. 2005 Oct 4;46(7):1307-8 [16198848.001]
  • [Cites] Circulation. 2004 Jun 29;109(25):3223-43 [15226233.001]
  • [Cites] Pacing Clin Electrophysiol. 2009 May;32(5):622-6 [19422583.001]
  • [Cites] J Natl Med Assoc. 2008 Feb;100(2):237-45 [18300541.001]
  • [Cites] Europace. 2007 Aug;9(8):613-20 [17636302.001]
  • [Cites] Int J Gynaecol Obstet. 2007 Jul;98(1):75-9 [17459386.001]
  • [Cites] Circulation. 1998 Sep 8;98(10):946-52 [9737513.001]
  • [Cites] JAMA. 1994 Mar 16;271(11):840-4 [8114238.001]
  • [Cites] Cardiol Clin. 2009 Feb;27(1):13-24, vii [19111760.001]
  • [Cites] J Cardiovasc Electrophysiol. 2007 Jan;18(1):23-8 [17081205.001]
  • [Cites] Am J Cardiol. 2009 Dec 1;104(11):1534-9 [19932788.001]
  • [Cites] Pacing Clin Electrophysiol. 1998 Nov;21(11 Pt 2):2455-8 [9825366.001]
  • [Cites] Gend Med. 2009 Sep;6(3):419-32 [19850238.001]
  • [Cites] Am J Cardiol. 2007 Sep 15;100(6):924-9 [17826371.001]
  • [Cites] Heart Rhythm. 2010;7(2):167-72 [20022814.001]
  • [Cites] JAMA. 2001 May 9;285(18):2370-5 [11343485.001]
  • (PMID = 28496679.001).
  • [Journal-full-title] Journal of atrial fibrillation
  • [ISO-abbreviation] J Atr Fibrillation
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


7. Khaykin Y, Skanes A, Wulffhart ZA, Gula L, Whaley B, Oosthuizen R, Seabrook C, Beardsall M, Verma A: Intracardiac ECHO Integration with Three Dimensional Mapping: Role in AF Ablation. J Atr Fibrillation; 2008 Jul-Aug;1(2):32
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • <b>Methods:</b> Between February and May 2007, 15 patients (100% men, 10 with paroxysmal AF) presenting for AF ablation were offered mapping using a novel system integrating 3D mapping and ICE.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cardiovasc Electrophysiol. 2007 Mar;18(3):276-82 [17284265.001]
  • [Cites] Circulation. 1999 Sep 14;100(11):1203-8 [10484541.001]
  • [Cites] J Cardiovasc Electrophysiol. 2004 Nov;15(11):1335-40 [15574190.001]
  • [Cites] Circ Arrhythm Electrophysiol. 2008 Jun 1;1(2):110-9 [19808401.001]
  • [Cites] J Am Coll Cardiol. 2002 Aug 7;40(3):464-74 [12142112.001]
  • [Cites] Heart Rhythm. 2007 May;4(5):595-602 [17467627.001]
  • [Cites] Circulation. 2000 Nov 21;102(21):2619-28 [11085966.001]
  • (PMID = 28496579.001).
  • [Journal-full-title] Journal of atrial fibrillation
  • [ISO-abbreviation] J Atr Fibrillation
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


8. Fulstow N: Men will be put off nursing by drive to bring back old-fashioned uniforms. Nurs Stand; 2009 Sep 09;24(1):32

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Men will be put off nursing by drive to bring back old-fashioned uniforms.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28090916.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


9. Men who have served in the armed forces at high risk of suicide. Nurs Stand; 2007 Aug 22;21(50):17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Men who have served in the armed forces at high risk of suicide.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28001552.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


10. Boys bullied at school risk depression in middle age. Nurs Stand; 2009 Mar 19;23(28):17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : The incidence of depression in middle-aged men might be associated with bullying at school.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28041163.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


11. Lung function declines quicker in highly hostile people. Nurs Stand; 2006 Nov 22;21(11):15

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Hostility is associated with poorer pulmonary function and more rapid rates of decline in older men.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28001891.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


12. Higher mortality rate in women infected after heart surgery. Nurs Stand; 2009 Sep 09;24(1):19

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Women who develop nosocomial infections while in intensive care have higher mortality rates than men.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28090878.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


13. Schneider A, Schuh A, Maetzel FK, Rückerl R, Breitner S, Peters A: Erratum to: Weather-induced ischemia and arrhythmia in patients undergoing cardiac rehabilitation: another difference between men and women. Int J Biometeorol; 2008 Jul;52(6):549

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Erratum to: Weather-induced ischemia and arrhythmia in patients undergoing cardiac rehabilitation: another difference between men and women.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumFor] Int J Biometeorol. 2008 Jul;52(6):535-47 [18228048.001]
  • (PMID = 28289917.001).
  • [ISSN] 1432-1254
  • [Journal-full-title] International journal of biometeorology
  • [ISO-abbreviation] Int J Biometeorol
  • [Language] eng
  • [Publication-type] Published Erratum
  • [Publication-country] United States
  •  go-up   go-down


14. Wang EM, Pan L, Wang BJ, Zhang N, Zhou LF, Dong YF, Dai JZ, Cai PW, Chen H: The long-term results of gamma knife radiosurgery for hemangioblastomas of the brain. J Neurosurg; 2005 Jan;102(s_supplement):225-229

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Thirty-five patients, 28 men and seven women, with a mean age of 36 years underwent GKS.
  • Eighteen patients presented with multiple tumors and 17 with a solitary tumor.
  • Twenty-one patients had von Hippel-Lindau (VHL) disease.
  • Although GKS can treat multiple tumors in a single session, for HABs associated with VHL disease, GKS faces the dual problems of tumor recurrence or development of a new tumor.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28306468.001).
  • [ISSN] 1933-0693
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; gamma knife surgery / hemangioblastoma / von Hippel—Lindau disease
  •  go-up   go-down


15. Singh G, Singh Bhinder H: Comparison of noncontact infrared and remote sensor thermometry in normal and dry eye patients. Eur J Ophthalmol; 2005 Nov - Dec;15(6):668-673

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The study was conducted on 51 dry eye cases (102 eyes), 26 men and 25 women aged 19 to 65 years (35.3614.36), and 51 normal (102 eyes) age- and sex-matched control subjects.
  • CONCLUSIONS: Remote sensor thermometry proved better for diagnosis of dry eye disease as it showed no change in temperature under closed chamber in closed and open position (p=0.0000).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28221433.001).
  • [ISSN] 1724-6016
  • [Journal-full-title] European journal of ophthalmology
  • [ISO-abbreviation] Eur J Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


16. Ito K, Elkin E, Morris M: Prevention of hip fractures in older men receiving androgen deprivation therapy for prostate cancer: A cost-effectiveness analysis. J Clin Oncol; 2009 May 20;27(15_suppl):6530

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prevention of hip fractures in older men receiving androgen deprivation therapy for prostate cancer: A cost-effectiveness analysis.
  • Our goal was to assess the cost-effectiveness of bone mineral density (BMD) screening followed by alendronate therapy at the onset of ADT in men with T2c-T4N0 prostate cancer.
  • METHODS: We developed a Markov model of prostate cancer progression and simulated the experience of 70-year-old men with T2c-T4N0 prostate cancer starting a 2-year course of ADT after radiation therapy.
  • We compared four strategies: No BMD screening and no alendronate therapy; BMD screening with alendronate therapy for men with osteoporosis (a T-score ≤ -2.5); BMD screening with alendronate therapy for men with osteoporosis or osteopenia (a T-score ≤ -1.0); and universal alendronate therapy without BMD screening.
  • Proportions of men who had a T-score ≤ -2.5 and -1.0 were 10% and 45%, respectively.
  • RESULTS: Compared with no screening and no therapy, BMD screening with alendronate therapy for men with osteopenia or osteoporosis cost $66,100 per QALY gained.
  • CONCLUSIONS: In men with T2c-T4N0 prostate cancer, BMD screening with alendronate therapy for men with osteoporosis or osteopenia is a cost-effective use of resources, compared with other medical interventions in oncology.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964040.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Halabi S, Sartor O, Petrylak D, Sternberg CN, Witjes JA, Noursalehi M, McKearn TJ, George MJ: Correlation of progression-free survival (PFS) and overall survival (OS) in men with metastatic castration-resistant prostate cancer (CRPC) who failed first-line chemotherapy: Results from the SPARC Trial. J Clin Oncol; 2009 May 20;27(15_suppl):5150

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Correlation of progression-free survival (PFS) and overall survival (OS) in men with metastatic castration-resistant prostate cancer (CRPC) who failed first-line chemotherapy: Results from the SPARC Trial.
  • The main objectives of this analysis were to explore whether PFS at 3-months is a predictor of OS and to investigate the dependence between PFS and OS in CRPC men who failed first line chemotherapy.
  • Finally, the association between OS and PFS was investigated using a statistic that estimates Kendall's tau measure of association for bivariate time to event outcomes subject to censoring.
  • RESULTS: 477 (56%) men progressed at 3-months of 853 men who were alive at 3-months.
  • The median survival times were 34.5 weeks (95% CI = 30.8-40.4) and 78.7 weeks (95% CI=70.1-83.2, p-value<0.001) respectively in men who did and did not experience progression at 3-months.
  • Men who had progressed at 3-months were more likely to die than men who did not progress (hazard ratio = 2.16, 95% CI =1.84 -2.55, p-value < 0.001).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964451.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Alibhai SM, Duong-Hua M, Sutradhar R, Cheung AM, Fleshner NE, Warde P, Paszat L: Bone health practices in men on androgen deprivation therapy (ADT): A population-based analysis of 25,802 patients. J Clin Oncol; 2009 May 20;27(15_suppl):9631

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bone health practices in men on androgen deprivation therapy (ADT): A population-based analysis of 25,802 patients.
  • : 9631 Background: ADT is used in up to 1 in 2 men with prostate cancer.
  • Guidelines recommend 2 important bone health practices for men on ADT - measurement of bone mineral density with dual x-ray absorptiometry (DEXA) and use of bisphosphonates in men at risk of osteoporosis.
  • METHODS: Using linked administrative databases, we identified 25,802 men (mean age 75.9 y, range 66-100 y) with prostate cancer who were treated with at least 6 months of ADT or who underwent bilateral orchiectomy in Ontario, Canada between 1995 and 2005.
  • RESULTS: Among 25,802 men, 3.09% had a DEXA more than one year prior to starting ADT, and 3.14% had a prior diagnosis of osteoporosis.
  • Rates of DEXA testing were higher among those with a prior diagnosis of osteoporosis, prior DEXA test, or prior fragility fracture but did not reach rates above 50 per 100 person-years in any of these groups.
  • More men on ADT were started on a bisphosphonate in the third year after starting ADT as compared to the second year, and rates were higher in year 2 than year 1.
  • Less than one-third of men starting a bisphosphonate underwent any DEXA testing within 12 months of bisphosphonate initiation.
  • CONCLUSIONS: Rates of DEXA testing and bisphosphonate use have increased over time among older men starting ADT, but significant gaps and delays remain in the quality of bone health care in this population.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963923.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Lin D, Smith MR, Morton RA, Steiner MS: Use of age and BMD to predict fracture risk in men on androgen deprivation therapy. J Clin Oncol; 2009 May 20;27(15_suppl):9517

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Use of age and BMD to predict fracture risk in men on androgen deprivation therapy.
  • We recently completed a two-year trial in 1382 men in which we examined the ability of toremifene to reduce fracture risk in men on ADT.
  • METHODS: We conducted a randomized double blind placebo controlled trial in 1382 men with histologically confirmed prostate cancer on ADT.
  • The primary end point was the incidence of new morphometric vertebral fractures.
  • To identify factors associated with fracture risk in men on ADT we compared placebo subjects who suffered a fracture or during the first year on study suffered 7% or greater bone loss with those placebo subjects who did not.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964492.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Renzaho A: Ischaemic Heart Disease and Australian Immigrants: The Influence of Birthplace and Language Skills on Treatment and Use of Health Services. HIM J; 2007 Jul;36(2):26-36

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ischaemic Heart Disease and Australian Immigrants: The Influence of Birthplace and Language Skills on Treatment and Use of Health Services.
  • Admission rates for ischaemic heart disease (IHD), and the use of invasive cardiovascular procedures, separation mode and length of stay (LOS) were compared between Australians from non-English speaking background (NESB; n=8627) and English speaking background (ESB; n=13162) aged 20 years and over admitted to Victorian urban public hospitals.
  • It was found that, compared with their ESB counterparts, the incidence of admission for acute myocardial infarction was significantly higher for NESB men and women before and after controlling for confounding factors.
  • Procedure rates were comparable in men for cardiac catheterisation and CABG but higher for PTA rates in NESB men (OR: 1.29, 95%CI: 1.11-1.50) than their ESB counterparts.
  • Both NESB men (β=0.04, 95%CI:0.01-0.07) and women (β=0.03, 95%CI: 0.02-0.08) experienced significantly longer hospital stays than their ESB counterparts.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28673173.001).
  • [ISSN] 1833-3575
  • [Journal-full-title] The HIM journal
  • [ISO-abbreviation] HIM J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Cross-Cultural Comparison / Ethnicity / Invasive Procedures / Ischaemic Heart Disease / Language Barriers / Length of Stay / Non-English Speaking Background / Physician-Patient Relations
  •  go-up   go-down


21. HIV rates are higher in men who use drugs for erectile dysfunction. Nurs Stand; 2010 Sep 15;25(2):15-17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] HIV rates are higher in men who use drugs for erectile dysfunction.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28019388.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


22. Hirsh AL, Lee DJ, Hruby G, Benson MC, McKiernan JM: Does the day or season of operation predict biochemical recurrence after radical prostatectomy? J Clin Oncol; 2009 May 20;27(15_suppl):e16162

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e16162 Background: Outcomes in hospital based medicine are associated with the experience and availability of the medical staff, as mortality and morbidity rates increase each summer with new medical graduates.
  • Hospital staff members are thought to be more fatigued and less available towards the end of the week and on weekends.
  • 1865 consecutive men underwent RP from 1991 to 2008 by three surgeons.
  • RESULTS: The mean age of the men undergoing RP was 61.2 years (37-79), with a mean preoperative PSA of 8.12.
  • 424 men (22.7%) had positive surgical margins, and the mean estimated blood loss (EBL) was 1119cc.
  • Men undergoing RP did not have different rates of BCR according to the day of the operation (p=0.58) or season (p=0.997).
  • These findings suggest that men undergoing RP do not need to be concerned about the particular season or day when scheduling the procedure.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963438.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. Hatcher D, Rose AE, Christos PJ, Mazumdar M, John M, Taneja SS, Lee P, Osman I: Impact of race on survival of prostate cancer patients treated with noncurative intent. J Clin Oncol; 2009 May 20;27(15_suppl):5069

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 5069 Background: We previously reported that African American (AA) men have a higher recurrence rate than Caucasian (CA) men treated with radical prostatectomy at the New York Veteran Administration Medical Center (NY-VAMC), an equal access to care facility (J Urol. 2006).
  • In the current study, we attempted to examine the differences in survival of AA and CA prostate cancer (PC) patients with clinically detected localized disease treated with non curative intent.
  • METHODS: Men diagnosed with PC at NY-VAMC during 1990-2005 were identified.
  • 2) no evidence of metastatic disease within 6 months after diagnosis;.
  • RESULTS: The study included 530 men (288 AA and 242 CA) with median follow-up of 8.1 years (range: 0.6-17.6 years).
  • AA men presented with significantly higher PSA compared to CA patients (median 18.5 versus 11.4 respectively, p = 0.004), however, there were no differences in age at presentation (median 73 versus 74, p = 0.98) or Gleason score (23% of AA and CA had Gleason >7, p = 0.92).
  • Of the 530 patients, 198 (37%) are alive with disease, 67 (13%) died of prostate cancer, 206 (39%) died of other causes, and 59 (11%) died of unknown causes.
  • Factors most predictive of mortality by Cox regression multivariable analysis were PSA at diagnosis (p = 0.001), Gleason score (p = 0.04), and age of patient at diagnosis (p < 0.0001).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964248.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. Ross RW, Bankaitis-Davis D, Siconolfi L, Katz L, Storm K, Magidson J, Wassmann K, Oh WK: Sensitivity and specificity of a whole-blood RNA transcript-based diagnostic test for the diagnosis of prostate cancer (CaP) compared with prostate-specific antigen (PSA) alone. J Clin Oncol; 2009 May 20;27(15_suppl):5052

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sensitivity and specificity of a whole-blood RNA transcript-based diagnostic test for the diagnosis of prostate cancer (CaP) compared with prostate-specific antigen (PSA) alone.
  • The goal of this study was to develop whole blood RNA transcript-based diagnostic tests that improve the diagnosis of CaP over PSA alone.
  • METHODS: From August 2006 to October 2008, three prospective cohorts of men consented to the collection of whole blood in PAXgene Blood RNA tubes for gene expression analysis: men with newly diagnosed, localized, untreated CaP, otherwise healthy men without CaP, and otherwise healthy men with BPH.
  • Logistic regression methods were used to develop models to optimize prostate cancer diagnosis.
  • RESULTS: 182 men underwent expression analysis (n = 76, 76 and 30 for CaP, normal, and BPH cohorts, respectively).
  • Considering only the CaP and normal cohorts, PSA alone (using a cut-off of 4 ng/ml) had a specificity of 94.7%, but sensitivity of only 71.1% for diagnosis of CaP, or 90.8% and 77.6%, respectively, when using age-adjusted PSA criteria.
  • A model consisting of the expression analysis of 6 genes and PSA had a higher specificity (96.1%) and a much improved sensitivity (97.4%) for CaP diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962956.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Sun C, Kurian S, Washington G, Nielsen-Menicucci K, Wilson T, Crocitto L, Donald S, Hanby C, Landier W, Smith S, Bhatia S: Differential survival after prostate cancer by race: Role of NCI-designated comprehensive cancer centers. J Clin Oncol; 2009 May 20;27(15_suppl):6520

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 6520 Background: A significant gap exists between Caucasians and African-Americans (AAs) in prostate cancer mortality, possibly due to sociodemographics, disease biology, or treatment.
  • METHODS: Using data from the Los Angeles Cancer Surveillance Program, we studied the underlying causes of differences in mortality in 18,790 men (AAs: 4,211; Caucasians: 14,579) diagnosed with prostate cancer between 1998 and 2003, and followed until 2006.
  • Three NCICCCs serve this area: USC-Norris, UCLA-Jonsson, and City of Hope.
  • RESULTS: Median age at diagnosis was 67.5 yrs; AAs were significantly more likely to have lower SES; carry no insurance; have distant disease; and be managed with "watchful waiting."

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964026.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


26. Pandurengan RK, Strom SS, Trent J 2nd: Gastrointestinal stromal tumor associated with other primaries: A study of 154 patients. J Clin Oncol; 2009 May 20;27(15_suppl):10567

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Multiple primaries included tumors that were not considered to be a metastasis, invasion or recurrence of GIST excluding non-melanoma skin cancer.
  • Data on gender, age at diagnosis of cancer, follow-up time after diagnosis, and death rate were collected.
  • The ratio of men and women was 1.5 and 1.3 in patients with GIST+ compared to those with GIST only, respectively.
  • Median age at diagnosis of GIST was 57 for patients with GIST only whereas it was 68 in patients with GIST+.
  • The total numbers of other primaries developed before the diagnosis of GIST was higher (134) than the primaries developed after the diagnosis of GIST (53).
  • The most frequent primaries observed before the diagnosis of GIST were prostate (25), breast (12), esophagus (9), kidney (7) and melanoma (6).
  • Lung (5) and kidney (5) were the most frequent type of primaries that developed after the diagnosis of GIST.
  • The 5-yr survival was 68% for patients with GIST+ when the other primary occurred before GIST, 61% for patients with GIST+ when the other primary occurred after the diagnosis of GIST, 58% for patients with GIST only, and 49% for GIST++ patients with two or more other primaries (p=0.002).
  • The etiology and clinical implications of the association of other primaries in GIST patients should be further investigated.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963788.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


27. Pomara G, Campo G, Milesi C, Casale P, Francesca F: How many lymph nodes may serve as a guideline for a sufficient extended lymph node dissection during radical prostatectomy? J Clin Oncol; 2009 May 20;27(15_suppl):e16102

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e16102 Background: Recent data suggest that extended lymph node (LN) dissection at radical prostatectomy (RP) may be necessary to detect occult positive lymph nodes, and that extended dissection may also have a positive impact on disease progression and long-term disease-free survival.
  • CONCLUSIONS: Compared to limited lymph node dissection (< 10 removed LNs), extended pelvic lymphadenectomy appears to identify men with positive lymph nodes more frequently.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963350.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


28. Janjigian YY, Park BJ, Kris MG, Miller VA, Riely GJ, Zheng J, Dycoco JP, Shen R, Azzoli CG: Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations. J Clin Oncol; 2009 May 20;27(15_suppl):7523

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations.
  • Adjuvant cisplatin-based chemotherapy improves disease free survival (DFS) and overall survival (OS) in patients with resected stages IB-IIIA NSCLC.
  • RESULTS: We studied 150 patients (112 women, 38 men) with completely resected stage I-III lung adenocarcinoma whose resection specimens contained EGFR activating mutations in exon 19 or 21.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963290.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


29. Harris AM, Eng TY, Karnad AB, Swanson GP, Jenkins C, Greene R: Tolerability of ongoing phase II study of concomitant radiation and docetaxel followed by docetaxel in prostate cancer patients with a persistent or rising PSA after radical prostatectomy. J Clin Oncol; 2009 May 20;27(15_suppl):e16054

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e16054 Background: Patients with a detectable PSA after radical prostatectomy (RRP) have persistent disease and inevitably succumb to disease as progression ensues.
  • It is of particular interest if adjuvant chemoradiation (CRT) can improve the rate of reaching a PSA nadir of zero after RRP in men with persistent or rising PSA.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963005.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


30. Homsi J, Bedikian AY, Kim KB, Papadopoulos NE, Hwu W, Mahoney S, Vardeleon AG, Davies M, Hwu P: Randomized trial of two schedules of palonosetron for the prevention of nausea and vomiting in patients with metastatic melanoma receiving interleukin-2-based concurrent biochemotherapy. J Clin Oncol; 2009 May 20;27(15_suppl):e20008

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Eighteen (60%) were men.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962592.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Patnaik A, Chiorean EG, Tolcher A, Papadopoulos K, Beeram M, Kee D, Waddell M, Gilles E, Buchbinder A: EZN-2968, a novel hypoxia-inducible factor-1α (HIF-1α) messenger ribonucleic acid (mRNA) antagonist: Results of a phase I, pharmacokinetic (PK), dose-escalation study of daily administration in patients (pts) with advanced malignancies. J Clin Oncol; 2009 May 20;27(15_suppl):2564

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Increased HIF-1α levels are associated with poor prognosis in several neoplasms.
  • RESULTS: 19 pts (11 men; median age = 60 y [47-79 y]) were treated with EZN-2968 doses of 0.5 (3 pts), 0.8 (3 pts), 1.2 (3 pts), 1.8 (4 pts), 2.7 (3 pts), and 4.1 (3 pts) mg/kg/day.
  • Stable disease was observed for 1 pt with angiosarcoma (28 wks) and 1 pt with renal cancer (12 wks).
  • Durable stable disease has been observed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961885.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Botan RD, Alvares MN, Hassan A: Male breast cancer: Prognostic factors evaluation in a 35-year service. J Clin Oncol; 2009 May 20;27(15_suppl):e11618

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although peculiar differences do exist between men and women, very little is known about the prognostic factors in male breast cancer, even though female breast cancer practical conducts are widely used in male breast cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961146.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


33. Demierre M, Whittaker S, Kim Y, Kim E, Piekarz R, Prince M, Nichols J, Balser J, Prentice A, Bates S, all investigators: Pooled analyses of two international, multicenter clinical studies of romidepsin in 167 patients with cutaneous T-cell lymphoma (CTCL). J Clin Oncol; 2009 May 20;27(15_suppl):8546

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 8546 Background: Romidepsin is a novel pan-HDAC inhibitor with demonstrated single-agent activity in 2 open-label clinical studies of 167 patients (pts) with CTCL [mycosis fungoides or Sézary Syndrome (SS)].
  • Pts recieved romidepsin, 14mg/m<sup>2</sup> as a 4-hr infusion on days 1, 8, and 15 every 28 days until disease progression (≥25% increase).
  • Mean age was 57±12 yrs, 67% men, 87% white.
  • 103 pts (76%) had stage ≥IIB disease.
  • CONCLUSIONS: Romidepsin is a valuable new therapy for pts with CTCL based on the ORR, CR, durability of response, improvement in all disease compartments and responses at all stages and in all subpopulations analyzed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27960961.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Karagiannis DA, Chatzistefanou K, Damanakis A: Prevalence of diplopia related to cataract surgery among cases of diplopia. Eur J Ophthalmol; 2007 Nov-Dec;17:914-918

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The authors retrospectively reviewed the medical records of 571 patients with diplopia over an 8-year period in order to evaluate the prevalence of diplopia related to cataract surgery.
  • Thirteen patients were men and 26 were women.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28221584.001).
  • [ISSN] 1724-6016
  • [Journal-full-title] European journal of ophthalmology
  • [ISO-abbreviation] Eur J Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


35. Brassell SA, Raymundo E, Chen Y, Zhao J: Impact of Asian American race on prostate cancer outcomes. J Clin Oncol; 2009 May 20;27(15_suppl):5165

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Men registered into the Center for Prostate Disease Research multi-center military national database from 1989-2007 with biopsy-proven CaP and categorized as Asian American, Caucasian, or African American descent were included.
  • Chi-square, ANOVA and Kruskal-Wallis test were used to examine association between race and clinico-pathologic features.
  • At diagnosis, Asian Americans had lower clinical stage (p<0.0001) but worse biopsy grade (p = 0.0006) than other groups.
  • They had a higher percentage of organ confined disease (p < 0.0001) and were more likely to choose radical prostatectomy (RP) (p < 0.0001).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964504.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


36. Kolevska T, Ryan CJ, Huey V, Weisberg L, Wang S, Baer D, Ghadialy A, Goldstein D, Fireman B, Fehrenbacher L: Phase II trial of nab-paclitaxel as first-line therapy of hormone refractory metastatic prostate cancer (HRPC). J Clin Oncol; 2009 May 20;27(15_suppl):5152

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The goal of this study was to evaluate the efficacy and toxicity of nab-paclitaxel in first line chemotherapy of men with castration resistant prostate cancer.
  • PSA response was PSA decrease of >50%, progressive disease (PD) was PSA increase of >25%, stable disease (SD) was <25% PSA increase or <50% decrease sustained longer that 8 weeks.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964449.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


37. Viret F, Ychou M, Baey C, Bennouna J, Adenis A, Peiffert D, Mornex F, Celier P, Montoto-Grillot C, Ducreux M: A phase II study of radiation and docetaxel and cisplatin in the treatment of locally advanced pancreatic carcinoma. FNCLCC-ACCORD 09 /0201 trial. J Clin Oncol; 2009 May 20;27(15_suppl):4625

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Patients (pts) received external beam radiotherapy (54 Gy in 1.8 Gy fractions, six weeks) and weekly chemotherapy regimen of association docetaxel and cisplatine (20 mg/m<sup>2</sup>/weeks each) for six weeks.
  • RESULTS: 51 pts (20 women and 31 men, with median age of 62 years) with disease considered to be unresectable but confined to pancreas area and celiac nodes were included between 06/10/2003 and 15/02/2008.
  • CONCLUSIONS: The association docetaxel+cisplatin+radiotherapy has limited effect in patients with locally advanced pancreatic carcinoma but major objective responses have been observed allowing secondary resections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964209.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Mika V, Hurd TC, Sunil T, Morning Star L, Moore F, Garcia O, Lopez L, Martinez M, Rios R, Welsh R: Lessons learned engaging Hispanic communities in cancer research. J Clin Oncol; 2009 May 20;27(15_suppl):1551

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These areas represent the diverse South Texas Mexican American population in terms of language use, immigration status, and length of time in the US.
  • RESULTS: Focus groups were conducted with women and men to assess knowledge, attitudes, and beliefs about women's cancers.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964101.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


39. Piulats JM Sr, Nadal M, Martinez-Iniesta M, Puertas S, Gonzalez S, Vidal A, Condom E, Germa-Lluch J, Garcia Del Muro X, Villanueva A: Nude mice model of primary human nonseminoma germ cell tumors to study biology and resistance to cisplatin treatment. J Clin Oncol; 2009 May 20;27(15_suppl):e16143

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e16143 Testicular germ cell tumors (TGCTs) are the most common malignancy in young men.
  • Whole genome analysis of tour xenografted tumors and their paired CDDP resistant tumor (#3 and #5 passage) were analyzed by CGH NimbeGen arrays using 60 Kb average windows.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963427.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


40. Guillotreau J Sr, Gamé X, Mouzin M, Doumerc N, Malavaud B, Rischmann P: Oncological outcomes of radical cystectomy for bladder cancer: Laparoscopy versus open surgery. J Clin Oncol; 2009 May 20;27(15_suppl):e16059

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A prospective non-randomized study was conducted between January 2003 and November 2008 in 52 patients, 2 women and 50 men, who underwent radical cystectomy for bladder cancer.
  • At the last follow-up 40 patients (76.9%) were alive with no evidence of disease and 5 (9.6%) died, two patients (3.8%) from metastasis and 3 (5.7%) from different causes.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962989.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


41. Arbona-Roche EI, Sucre C, Vera-Gimón R, Vera-Gimón A, Vera-Vera R, Gutierrez E, Urdaneta N, Gutierrez M, Somaza S, Tremont-Lukats IW: Treatment of glioblastoma in Venezuela: Limitations using the current standard of care. J Clin Oncol; 2009 May 20;27(15_suppl):e13036

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The median age was 51 years; 17 (60%) were men; 27 (90%) had biopsy or partial resection; 27 (90%) took prophylactic anticonvulsants; and 23 (77%) had prophylaxis against P. jiroveci.
  • One patient had Stevens-Johnson syndrome and did not complete RT.
  • Twelve (40%) patients had stereotactic radiosurgery for recurrent disease during the adjuvant phase.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962860.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


42. Pramesh CS, Mistry RC: Perioperative morbidity and mortality after radical lymphadenectomy for operable esophageal cancer. J Clin Oncol; 2009 May 20;27(15_suppl):e15554

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Six hundred and forty five patients (453 men, 192 women, mean age 53.6 years, range 19-76 years) were operated by transthoracic total esophagectomy for esophageal cancer between October 2003 and December 2007.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962335.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


43. Siemerink E, Schaapveld M, Hospers GA, Mulder NH, Plukker JT: Effect of hospitals on survival and postoperative mortality of stomach cancer: A population-based study on type, referral, and volume-effect in the northeast Netherlands. J Clin Oncol; 2009 May 20;27(15_suppl):e15564

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This area is served by one university hospital (U), 4 teaching hospitals (T), and 18 non-teaching hospitals (N-T).
  • RESULTS: In the study period, 5243 patients were diagnosed with stomach cancer (65.6% men, 34.4% female), 44.5% underwent surgery.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962324.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Mohri Y, Kageyama S, Mohri T, Tanaka K, Ohi M, Yokoe T, Kusunoki M: Macrophage migration inhibitory factor and long-term survival in gastric cancer. J Clin Oncol; 2009 May 20;27(15_suppl):e15525

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: One hundred five patients, 73 men and 32 women, mean (±SD) age 63±14 years, with histologically proven gastric adenocarcinoma were included in the study.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962256.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


45. Rosen L, Gordon MS, Hurwitz HI, Wong MK, Adams BJ, Alvarez D, Seon BK, Leigh BR, Theuer CP: Early evidence of tolerability and clinical activity from a phase I study of TRC105 (anti-CD105 antibody) in patients with advanced refractory cancer. J Clin Oncol; 2009 May 20;27(15_suppl):3518

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: 19 ECOG PS 0-1 patients received TRC105 at doses between 0.01-1.0 mg/kg, including 11 men and 8 women aged 37 to 79 years (median 59).
  • In addition, 6-month stable disease was seen in a patient with ovarian cancer (CA125 decrease of 16%).
  • Best response also included stable disease (n = 3) and progression (n = 14).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961300.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


46. MacVicar GR, Greco A, Reeves J, Maleski J, Holmlund J, Leopold L: An open-label, multicenter, phase I/II study of AT-101 in combination with docetaxel (D) and prednisone (P) in men with castrate-resistant prostate cancer (CRPC). J Clin Oncol; 2009 May 20;27(15_suppl):5062

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An open-label, multicenter, phase I/II study of AT-101 in combination with docetaxel (D) and prednisone (P) in men with castrate-resistant prostate cancer (CRPC).
  • METHODS: Men ≥18 years of age with chemotherapy-naïve CRPC (N = 36).
  • Radiological assessments were performed at 6-wk intervals for pts with soft tissue disease and bone scans were performed after cycle 6 and at the completion of therapy.
  • Nine of 19 pts (47%) with measurable disease had a PR.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962977.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


47. Ill-fitting condoms result in breakages and early removal. Nurs Stand; 2010 Mar 31;24(30):16-17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Men and their female sex partners may benefit from public health efforts designed to promote the improved fit of condoms.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28029896.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


48. Lunchtime napping reduces the risk of coronary death. Nurs Stand; 2007 Apr 11;21(31):15

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Healthy individuals, particularly working men, who take a siesta are at reduced risk of mortality from coronary artery disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27967633.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


49. Resting, exercise and recovery pulse rate predicts sudden death. Nurs Stand; 2005 Jul 20;19(45):20-21

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Heart rate profile during exercise and recovery from exercise is a predictor of sudden death in men.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27978025.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


50. Etzersdorfer E, Voracek M, Kapusta N, Sonneck G: Epidemiology of suicide in Austria 1990-2000 : General decrease, but increased suicide risk for old men. Wien Klin Wochenschr; 2005 Jan;117(1-2):31-35

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiology of suicide in Austria 1990-2000 : General decrease, but increased suicide risk for old men.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28124173.001).
  • [ISSN] 1613-7671
  • [Journal-full-title] Wiener klinische Wochenschrift
  • [ISO-abbreviation] Wien. Klin. Wochenschr.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Austria
  • [Keywords] NOTNLM ; Austria / Epidemiology / Suicide / Suicide prevention
  •  go-up   go-down


51. Risk of lung cancer much higher in men exposed to wood dust. Nurs Stand; 2008 Dec 03;23(13):15

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Risk of lung cancer much higher in men exposed to wood dust.
  • However, evidence of its association with other upper aero-digestive tract and respiratory cancers has been inconsistent.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28010359.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


52. Martí N, Ramón D, Gámez L, Reig I, García-Pérez MÁ, Alonso V, Jordá E: Botulinum Toxin Type A for the Treatment of Primary Hyperhidrosis: A Prospective Study of 52 Patients. Actas Dermosifiliogr; 2010 Sep;101(7):614-621

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Toxina Botulínica A en el tratamiento de la hiperhidrosis primaria: estudio prospectivo de 52 pacientes.
  • MATERIAL AND METHODS: The study included 52 patients (39 women and 13 men) with a diagnosis of primary hyperhidrosis treated for the first time with BTX-A.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2009 Elsevier España, S.L. y AEDV. All rights reserved.
  • (PMID = 28709543.001).
  • [ISSN] 1578-2190
  • [Journal-full-title] Actas dermo-sifiliograficas
  • [ISO-abbreviation] Actas Dermosifiliogr
  • [Language] eng; spa
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  • [Keywords] NOTNLM ; Botulinum toxin A / Escala de severidad de la hiperhidrosis / Hiperhidrosis primaria / Hyperhidrosis disease severity scale / Primary hyperhidrosis / Toxina botulínica A
  •  go-up   go-down


53. Moghimi S, Riazi Esfahani M, Maghsoudipour M: Visual function after implantation of aniridia intraocular lens for traumatic aniridia in vitrectomized eye. Eur J Ophthalmol; 2007 Jul-Aug;17:660-665

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two patients were men and two women with mean age of 39.25 years.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28221565.001).
  • [ISSN] 1724-6016
  • [Journal-full-title] European journal of ophthalmology
  • [ISO-abbreviation] Eur J Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


54. Perdicchi A, Iester M, Scuderi G, Amodeo S, Medori EM, Recupero SM: Visual field damage and progression in glaucomatous myopic eyes. Eur J Ophthalmol; 2007 Jul-Aug;17:534-537

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A total of 110 patients with POAG (52 men and 58 women) were included in the study.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28221546.001).
  • [ISSN] 1724-6016
  • [Journal-full-title] European journal of ophthalmology
  • [ISO-abbreviation] Eur J Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


55. Resch MD, Bausz M, Nagy Z, Suveges I: Corneal topography parameters after superior clear corneal incision cataract surgery in arcus lipoides. Eur J Ophthalmol; 2006 Jan - Feb;16(1):24-29

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Fourty eyes of 40 patients (23 women, 17 men, age 71.3+/-20.4 years, range 40 to 89 years) were studied prospectively in a consecutive, non-interventional, comparative series of cases.
  • Keratometric astigmatism (Dcyl), surface regularity index (SRI), surface asymmetry index (SAI), and potential visual acuity (PVA) were evaluated for the different groups and time-points, using the Kruskal-Wallis, Wilcoxon, and Mann-Whitney statistical tests.
  • RESULTS: No significant preoperative difference was found in mean Dcyl, SRI, or PVA; preoperative SAI was lower in Group 1.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28221482.001).
  • [ISSN] 1724-6016
  • [Journal-full-title] European journal of ophthalmology
  • [ISO-abbreviation] Eur J Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


56. Novais PC, Paula AA, Rodrigues AA Jr, Barione DF, Peria FM, Tirapelli DP, Tucci S Jr, Cologna AJ, Martins AC, Tirapelli LF: Apoptotic genes as a prognostic factor in penile epidermoid carcinoma. J Clin Oncol; 2009 May 20;27(15_suppl):e22208

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e22208 Background: The penile cancer is a rare condition in European men.
  • The comprehension of the disease behavior can provides new, non-invasive therapeutic interventions.
  • Therefore, this study can contribute with information about this disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964136.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


57. Dumont AG, Lev D, Lazar A, Joensuu H, Trent J: Simultaneous gastrointestinal stromal tumor (GIST) and desmoid fibromatosis (DF). J Clin Oncol; 2009 May 20;27(15_suppl):10568

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Our patients were three men and three women aged from 39 to 66.
  • The association of these two sarcomas should be further explored.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963790.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. Barbera LC, Krzyzanowska M, Elit L, Saskin R, Bierman A: Differences in uptake of postoperative adjuvant chemotherapy for lung cancer: Results from the Project for an Ontario Women's Health Evidence-Based Report Card (POWER) study. J Clin Oncol; 2009 May 20;27(15_suppl):6556

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There was no difference in chemotherapy use between men or women or by neighbourhood income quintile.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963771.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


59. Flores RM, Riedel E, Donington JS, Krug L, Rosenzweig K, Adusumilli P, Carbone M, Rusch VW, Pass HI: Frequency of use and outcome of surgical resection in the management of malignant mesothelioma in a community-based population: Results in 5,937 patients. J Clin Oncol; 2009 May 20;27(15_suppl):7510

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We undertook this study to evaluate the rate of surgical resection and its association with survival in a non-tertiary based population.
  • METHODS: The Surveillance, Epidemiology, and End Results (SEER) database was searched from 1990 - 2004.
  • Variables analyzed included age, sex, race, year of diagnosis, laterality, vital status, stage, surgery, and reasons for no surgery.
  • The association of resection on overall survival was estimated by the Kaplan-Meier method and examined in a Cox proportional hazards model adjusting for covariates.
  • RESULTS: Pathologically proven malignant pleural mesothelioma was identified in 5,937 patients: 1,166 women, 4,771 men; median age was 70 years.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963481.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


60. Hauke RJ, Enke C: Phase I study of extended field intensity modulated radiation therapy (EF-IMRT) and docetaxel in patients with node-positive prostate cancer. J Clin Oncol; 2009 May 20;27(15_suppl):e16154

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We conducted a phase I study combining HAT with EF-IMRT and concurrent docetaxel in men with biopsy-proven node positive prostate cancer.
  • METHODS: Eligible patients had biopsy proven N1M0 disease and adequate hematologic and hepatic function.
  • All subjects received neoadjuvant HAT (bicalutamide 50 mg/d with an LHRH agonist) for at least 2 months but less than 13 months prior to EF-IMRT and continued for 2 years after completion of radiation (bicalutamide discontinued at the end of radiation).
  • Seven of 9 patients are now beyond the 2 year post-radiation period; 4 patients remain in remission; one patient developed primary lung cancer; another was lost to follow up at 1 year post-radiation and 3 had relapsed disease within the 2 year post-radiation window.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963414.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


61. von Boehmer L, Wild P, Keller L, Hermanns T, Provenzano M, Sais G, Jaeger E, Stenner F, Moch H, Knuth A: Cancer testis antigen expression and immune responses by prostate cancer patients: Implications for prognosis and immunotherapy. J Clin Oncol; 2009 May 20;27(15_suppl):e16101

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e16101 Background: Prostate cancer (PC) is the most frequent malignancy in men and it continues to be one of the most common fatal cancers.
  • Little is known about CT antigen expression in relation to disease progression.
  • METHODS: To determine the expression of 6 CT antigens in prostate cancer immunohistochemistry was performed on tissue micro arrays.
  • As an exception we found MAGE-C2 to be expressed early in the course of disease, frequently inducing MAGE-C2 specific antibodies.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963349.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


62. Gallego R, Fuster D, Ginés A, Ortín J, Ayuso JR, Momblan D, Arguis P, Conill C, Pons F, Maurel J: Usefulness of PET/CT in the diagnosis of distant metastases of potentially operable gastric adenocarcinoma. J Clin Oncol; 2009 May 20;27(15_suppl):e15598

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Usefulness of PET/CT in the diagnosis of distant metastases of potentially operable gastric adenocarcinoma.
  • 1) To evaluate the usefulness of Positron Emission Tomography with combined 18F-Fluorodeoxyglucose with Computed Tomography (PET/CT) in the diagnosis of distant metastases in patients with gastric adenocarcinoma (GAC) compared to spiral double contrast thoracoabdominal Computed Tomography (CT);.
  • METHODS: Thirty prospective patients (22 men, 8 women; mean age 67±11) who underwent endoscopic ultrasound and were classified as T2-3N1 or T3Nx GAC were included in this study.
  • In 1/3 patients with histopathological confirmed diagnosis of peritoneal carcinomatosis by laparoscopic findings was negative by PET/CT, and considered as a false negative case.
  • 1) PET/CT is useful in the diagnosis of distant metastases in patients with GAC 2) Further studies are needed to establish the role of PET/CT to detect peritoneal carcinomatosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962880.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


63. Matsumoto K, Sawaki A, Kobayashi Y, Mizuno N, Hara K, Takagi T, Sawai Y, Shimizu Y, Yatabe Y, Yamao K: Diagnostic yield of nonfunctional pancreatic neuroendocrine tumor using endoscopic ultrasound-guided fine needle aspiration biopsy. J Clin Oncol; 2009 May 20;27(15_suppl):e15680

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e15680 Background: Radiological examinations including computed tomography (CT) and endoscopic ultrasound sonography (EUS) are important for the diagnosis of pancreatic neuroendocrine tumors (PNETs).
  • Pathological diagnosis is not needed with functional PNETs because the diagnosis is made by biochemical testing.
  • Therefore, pathological diagnosis is essential for the non-functional PNETs (nf-PNETs).
  • RESULTS: 16 patients (10 men and 6 women) who ranged in age from 23 to 81 years.
  • Diagnosis by CT and EUS was 12 (75.0%) PNETs, two pancreatic cancer, one solid papillary tumors and one malignant lymphoma.
  • Accurate diagnosis by cytology and immunohistochemistry was 75.0% and 93.8%, respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962818.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


64. Luketich J, Pennathur A, Catalano PJ, Swanson SJ, de Hoyos AL, Maddaus MA, Nguyen N, Benson AB 3rd, Fernando HC: Results of a phase II multicenter study of minimally invasive esophagectomy (Eastern Cooperative Oncology Group Study E2202). J Clin Oncol; 2009 May 20;27(15_suppl):4516

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: We entered 106 patients (men 84%; women 22%; median age 64, range 36-83) into the study from 16 institutions in the United States (ECOG, CALGB, ACOSOG).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962698.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


65. Blasco A, Galan A, Almenar D, Gironés R, Diaz R, Alberola V: Pain, depression, asthenia, and insomnia: Prevalence of this symptoms cluster and its impact on health-related quality of life in a cohort of advanced cancers. J Clin Oncol; 2009 May 20;27(15_suppl):e20607

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: An observational and longitudinal multicentre study was carried out on a sample of cancer pts with breast, lung or colon cancer, any site and period of disease duration, receiving chemotherapy.
  • Sociodemographic data, key clinical indicators, as well as P, D, A and I complaints or diagnosis were collected.
  • RESULTS: A total of 116 pts were analyzed: 73.3 men, 61 years old (SD=9,1), 2.9 years (SD=2,3) since diagnosis, 16.4 % breast, 54.3% lung, and 29.3% colon cancer; 97.4% with metastasis.
  • Pts could be classified in 13 of the 15 symptoms cluster possible combinations (according to their symptoms complaints/diagnosis) ranging from 0.9% to 12.9%.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961554.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


66. Purnell JQ, Palesh O, Mustian K, Peppone L, Morrow G, Colman LK, Lord R, Flynn PJ: Cancer-related self-efficacy in African American prostate cancer patients compared to whites. J Clin Oncol; 2009 May 20;27(15_suppl):5067

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 5067 Background: African American (AA) men are nearly twice as likely as white (W) men to be diagnosed with prostate cancer.
  • CONCLUSIONS: Results suggest that, compared to W men, AA men have less confidence in their ability to cope with prostate cancer following diagnosis.
  • AA men report the least confidence in their ability to cope with the possibility of death as a result of cancer, and they also report less confidence in their ability to focus and relax.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964250.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


67. Calvini P, Chincarini A, Gemme G, Penco MA, Squarcia S, Nobili F, Rodriguez G, Bellotti R, Catanzariti E, Cerello P, De Mitri I, Fantacci ME, MAGIC-5 Collaboration, Alzheimer's Disease Neuroimaging Initiative (ADNI): Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease. Med Phys; 2009 Aug;36(8):3737-3747

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease.
  • The purpose of this study is to develop a software for the extraction of the hippocampus and surrounding medial temporal lobe (MTL) regions from T1-weighted magnetic resonance (MR) images with no interactive input from the user, to introduce a novel statistical indicator, computed on the intensities in the automatically extracted MTL regions, which measures atrophy, and to evaluate the accuracy of the newly developed intensity-based measure of MTL atrophy to (a) distinguish between patients with Alzheimer disease (AD), patients with amnestic mild cognitive impairment (aMCI), and elderly controls by using established criteria for patients with AD and aMCI as the reference standard and (b) infer about the clinical outcome of aMCI patients.
  • For the development of the software, the study included 61 patients with mild AD (17 men, 44 women; mean age±standard deviation (SD), 75.8years±7.8; Mini Mental State Examination (MMSE) score, 24.1±3.1), 42 patients with aMCI (11 men, 31 women; mean age±SD, 75.2years±4.9; MMSE score, 27.9±1.9), and 30 elderly healthy controls (10 men, 20 women; mean age±SD, 74.7years±5.2; MMSE score, 29.1±0.8).
  • For the evaluation of the statistical indicator, 150 patients with mild AD (62 men, 88 women; mean age±SD, 76.3years±5.8; MMSE score, 23.2±4.1), 247 patients with aMCI (143 men, 104 women; mean age±SD, 75.3years±6.7; MMSE score, 27.0±1.8), and 135 elderly healthy controls (61 men, 74 women; mean age±SD, 76.4years±6.1).
  • Fifty aMCI patients were evaluated every 6 months over a 3 year period to assess conversion to AD.
  • An intensity-based MTL atrophy measure was found to separate control, MCI, and AD cohorts.
  • Compared to controls, significant differences in the intensity-based MTL atrophy measure were detected in both groups of patients (AD vs controls, 0.28±0.03 vs 0.34±0.03, P<0.001; aMCI vs controls, 0.31±0.03 vs 0.34±0.03, P<0.001).
  • Regarding the ROC curve for intergroup discrimination, the area under the curve was 0.863 for AD patients vs controls, 0.746 for all aMCI patients vs controls, and 0.880 for aMCI converters vs controls.
  • With specificity set at 85%, the sensitivity was 74% for AD vs controls, 45% for aMCI vs controls, and 83% for aMCI converters vs controls.
  • The automated analysis of MTL atrophy in the segmented volume is applied to the early assessment of AD, leading to the discrimination of aMCI converters with an average 3 year follow-up.
  • This procedure can provide additional useful information in the early diagnosis of AD.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2009 American Association of Physicists in Medicine.
  • (PMID = 28541615.001).
  • [ISSN] 2473-4209
  • [Journal-full-title] Medical physics
  • [ISO-abbreviation] Med Phys
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Alzheimer disease / Brain / Computer software / Dementia / Image analysis / Image registration / MRI: anatomic, functional, spectral, diffusion / Magnetic resonance / Magnetic resonance imaging / Medical image segmentation / Medical imaging / Medical magnetic resonance imaging / Time measurement / biomedical MRI / brain / diseases / hippocampus / image analysis / magnetic resonance imaging / medical image processing / neurophysiology / patient diagnosis
  •  go-up   go-down


68. Holland D: I have experienced a lot of negativity about my gender. Nurs Stand; 2009 Sep 09;24(1):32

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : I read with interest your news story 'Negative stereotypes prevent men from entering the profession' (August 26).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28090918.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


69. Harrison M: Fifty per cent of society is still undervalued in nursing. Nurs Stand; 2009 Nov 11;24(10):33

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Other men often say they think I am too assertive to be a nurse.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28061101.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


70. 'Despicable' attack on district nurse adds to fear of violence. Nurs Stand; 2007 Aug 01;21(47):11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Police are hunting a gang of four men who robbed and terrorised a district nurse as she visited a patient at home in the afternoon.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28001601.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


71. Turner C: Patients at my IVF unit say they value male nurses' care. Nurs Stand; 2009 Sep 23;24(3):33

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Further to your news story 'Negative stereotypes prevent men from entering the profession' (August 26), I believe an increased proportion of male nurses would benefit nursing.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28064742.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


72. Government 'ignores' lack of male nurses. Nurs Stand; 2007 Jun 06;21(39):10

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : The government's lack of action to attract men into nursing proves ministers are only interested in addressing inequality when women are the victims, according to a Tory MP.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28006644.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


73. Campaign highlights blood pressure risk. Nurs Stand; 2007 Feb 14;21(23):8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Men who have a West African heritage are being encouraged to have their blood pressure checked as part of a campaign by nurses in south London.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27986019.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


74. Inquiry to focus on profession's gender balance. Nurs Stand; 2006 Feb 22;20(24):10

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : An inquiry that will examine whether recruitment into nursing is biased against men was launched last week by the Equal Opportunities Commission (EOC).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27977975.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


75. Warriner J: We need to see evidence on risks of gay men giving blood. Nurs Stand; 2009 Nov 11;24(10):33

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] We need to see evidence on risks of gay men giving blood.
  • : There were a couple of errors in the news story 'Call for end to ban on gay men giving blood' (November 4).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28061104.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


76. Yung RL, Kurth T, Gaziano JM, Driver JA: Cancer aggressiveness and mortality in men of exceptional age. J Clin Oncol; 2009 May 20;27(15_suppl):11051

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cancer aggressiveness and mortality in men of exceptional age.
  • : 11051 Background: Information on the characteristics of cancer in people ≥ 85 is limited, particularly in men.
  • METHODS: We evaluated the type, grade and extent of cancer among the 22,071 men in the Physicians' Health Study by age at diagnosis (dx) (<65, 65-74, 75-84 and ≥85).
  • All cases of cancer, deaths and cause of death were confirmed by medical record review.
  • For men ≥ 85 the frequency of metastatic cancer at dx increased for prostate (5.8% vs 14.6% p=0.01) and decreased for other GI tumors (63.8% vs 43.5% p=0.05).
  • Cancer as a cause of death decreased among the entire cohort from 44.1% in men aged 55-64 to 20.5% in men ≥ 85, and among those with cancer it decreased from 93.6% to 52.8%.
  • In the matched cohort analysis, the HR for death from all cancers combined declined markedly across categories of increasing age at cancer dx from 10.9 (95%CI:6.0-19.9) in men < 55 to 1.9 (95%CI:1.5-2.4) in men ≥ 85.
  • CONCLUSIONS: In this prospective cohort of apparently healthy U.S. male physicians, characteristics of cancer in men ≥ 85 varied considerably with tumor type and may reflect changes in cancer detection or biology with age.
  • Cancer specific mortality decreased markedly with increasing age of diagnosis for most cancers.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963157.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


77. King MT, Viney R, Hossain I, Smith D, Savage E, Stockler MR, Armstrong B: Survival gains needed to justify the side effects of treatment for localized prostate cancer. J Clin Oncol; 2009 May 20;27(15_suppl):5119

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 5119 Background: Men diagnosed with localized prostate cancer face difficult treatment decisions.
  • METHODS: QOL data were collected prospectively 3 years post-diagnosis in a population-based cohort of men treated for localized prostate cancer (n=1642); these data were used to identify common side-effect profiles.
  • RESULTS: The table shows the survival gains needed for a range of common treatment profiles, relative to the base case of active surveillance (in which men typically experienced mild loss of libido and mild fatigue).
  • For example, radical prostatectomy often resulted in severe impotence and mild urinary leakage; men required an extra 8.0 months (95% CI 7.4-8.7) of life to make this worthwhile.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964386.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


78. Silica exposure associated with rheumatoid arthritis. Nurs Stand; 2005 May 18;19(36):19

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Men who work in industries involving rock drilling or stone grinding, and are thus exposed to silica, are at increased risk of developing rheumatoid arthritis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27985205.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


79. Rees C: A handbook of men's health Laws Tom A handbook of men's health Elsevier 214pp £19.99 0 443 073384 0443073384 [Formula: see text]. Nurs Stand; 2006 May 24;20(37):30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A handbook of men's health Laws Tom A handbook of men's health Elsevier 214pp £19.99 0 443 073384 0443073384 [Formula: see text].
  • : Men's health is a neglected topic in nursing literature.
  • This compact reference book provides essential clinical and social information to improve the nursing care men receive.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27958908.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


80. Shim K, Potvin KR, Mills K, Whiston F, Stitt L, Winquist E: Risk factors for thromboembolic events in testicular cancer patients receiving chemotherapy. J Clin Oncol; 2009 May 20;27(15_suppl):e16109

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Clinical experience and the literature have suggested that men receiving cisplatin-based chemotherapy for metastatic germ cell tumors are at particularly high risk.
  • METHODS: All men treated with cisplatin-based chemotherapy for metastatic germ cell cancer at the London Regional Cancer Program from January 1978 to December 2007 were identified from electronic databases.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963332.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


81. Cescon DW, Canil C, Le LW, Tannock IF: Use of the Prostate Cancer-specific Quality of Life Instrument (PROSQOLI) in clinical practice. J Clin Oncol; 2009 May 20;27(15_suppl):e20569

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e20569 Background: Improvement of quality of life (QOL) is a major therapeutic goal for men with advanced prostate cancer (APC).
  • RESULTS: 36 men were recruited, and data collected from 120 clinic visits (85 phase I, 35 phase II).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961125.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


82. Lawrence YR, Morag O, Boyko V, Benderly M, Goldbourt U, Barchana M, Behar S, Wolf I, Dicker AP, Catane R: Metabolic syndrome, diabetes mellitus, and the subsequent development of prostate cancer. J Clin Oncol; 2009 May 20;27(15_suppl):5158

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metabolic syndrome, diabetes mellitus, and the subsequent development of prostate cancer.
  • Metabolic syndrome (MS) is a cluster of medical disorders (hypertension, dyslipidaemia, hyperglycaemia, obesity) associated with the subsequent development of diabetes mellitus (DM).
  • METHODS: The Bezafibrate Infarction Prevention study was a randomized trial of fibrate therapy for the secondary prevention of ischemic heart disease.
  • Between 1990-2 15524 men and women with ischemic heart disease were screened, of whom 3090 entered the trial.
  • DM was defined by medical history or fasting glucose > 125 mg/dL.
  • RESULTS: 1350 participants were excluded due to missing data or previous cancer diagnosis, leaving 11,541 men.
  • CONCLUSIONS: A baseline diagnosis of DM (highly significant) or MS (trend) was associated with a decreased prostate cancer rate over the subsequent 12 years.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964472.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


83. Olsson H, Attner B, Noreen D, Lithman T: Comorbidity prior to diagnosis in patients with common cancer diagnoses. J Clin Oncol; 2009 May 20;27(15_suppl):e22180

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comorbidity prior to diagnosis in patients with common cancer diagnoses.
  • : e22180 Background: Chronic disease as diabetes, hypertonia and anemia may be associated with cancer risk as well as affect the short term survival of the malignancy.
  • Comorbidity was studied prior to cancer diagnosis and in order to compare with the general population all first comorbidity diagnoses within 90 days were censored.
  • Patients with lung cancer had a higher prevalence of anemia, KOL, diabetes, rheumatoid arthritis for both men and women and for men also a higher prevalence of alcohol related diseases.
  • Survival of the different cancer diagnoses was not significantly related to the comorbidity except for a tendency of worse survival for patients with alcohol related disease.
  • Our study also indicates the necessity to have all levels of care included in the study base of comorbidity and also emphasizes the need to censor time prior to diagnosis when comparing data with the general population.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963595.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


84. Granberg C, Thompson RH, Quevedo JF, Karnes RJ, Frank I, Kwon ED, Blute ML: Down-staging of locally advanced prostate cancer with anti-CTLA-4 monoclonal antibody prior to radical prostatectomy. J Clin Oncol; 2009 May 20;27(15_suppl):e16103

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e16103 Background: At present, androgen ablation (AA) therapy ± radiation therapy represents a first-line treatment for patients with unresectable locally advanced prostate cancer (CAP), typically resulting in palliative disease control.
  • Here, we discuss the outcomes of 5 locally advanced CAP patients treated with the monoclonal antibody MDX-CTLA-4 (MDX-010) + AA who subsequently underwent radical prostatectomy (RP), 2 of whom exhibited striking down-staging of their disease.
  • RESULTS: All men had unresectable, locally advanced disease (stage T2c-T4) prior to treatment with AA + MDX-010 and subsequently underwent RP.
  • Of the 5 patients, 2 exhibited dramatic and indisputable down-staging of their disease.
  • Both had T4 disease pre-treatment, and had stage T2c on final pathology.
  • One patient is free of disease with undetectable PSA for 19 months following adjuvant radiation treatment but no further therapy, while the other patient is awaiting follow-up.
  • This therapeutic modality exhibits significant promise for men with unresectable disease and may provide durable and potentially curative cancer control.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963333.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


85. Pohl A, Zhang W, Yang D, Lurje G, Ning Y, Khambata-Ford S, Langer C, Kahn M, Teo JL, Lenz HJ: Association of CD133 polymorphisms and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with either first-line 5-FU + bevacizumab (BV) or second-line irinotecan (IR)/cetuximab (CB) or IR alone. J Clin Oncol; 2009 May 20;27(15_suppl):4062

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association of CD133 polymorphisms and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with either first-line 5-FU + bevacizumab (BV) or second-line irinotecan (IR)/cetuximab (CB) or IR alone.
  • RESULTS: 79 pts (47 men, 32 women) received FOLFOX/BV or XELOX/BV.
  • The second cohort consisted of 186 pts (103 men, 83 women).
  • Combined analysis of rs2286455 and rs3130 showed a significant association with PFS (p= 0.010, log-rank test) in pts receiving FOLFOX/BV or XELOX/BV.
  • Multivariate analysis showed a significant association with PFS in first-line setting for rs2286455 and rs3130 (adjusted p=0.012) and a trend in second-line setting for rs2240688 (adjusted p=0.086).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961591.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


86. Snyder CF, Frick KD, Blackford AL, Herbert RJ, Neville BA, Carducci MA, Earle CC: Costs of treatments for local/regional prostate cancer. J Clin Oncol; 2009 May 20;27(15_suppl):6527

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 6527 Background: Men with prostate cancer have a variety of treatment options, including surgery, radiation, hormonal therapy, combinations thereof, or active surveillance.
  • METHODS: Using the SEER-Medicare database, we examined the Inpatient, Outpatient, Emergency, and Other costs of men diagnosed with local/regional prostate cancer in the year 2000 who were 66+ years old and enrolled in the fee-for-service Medicare program.
  • Based on the treatments received in the first 9 months from diagnosis, men were assigned to these treatment groups: active surveillance, radiation, hormonal, hormonal+radiation, surgery (might also include radiation and hormonal therapy).
  • We estimated the costs of prostate cancer care from 1 month pre- to 12 months post-diagnosis by calculating the incremental costs of care for cases vs.
  • CONCLUSIONS: The treatment choice of men with local/regional prostate cancer has important implications for cost in the year following diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964033.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


87. Webwise. Nurs Stand; 2010 Mar 31;24(30):30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Colorectal cancer is common in the UK, with 37,500 people diagnosed and 16,000 dying with the disease each year.
  • It is the second largest cause of cancer deaths, affecting men and women equally.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28029876.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


88. Walsh T: Dementia patients were not starved, inquest finds. Nurs Stand; 2005 Mar 30;19(29):6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : ELEVEN OLDER men whose deaths in a hospital ward in the 1990s sparked accusations that they had been starved by nursing staff died from natural causes, an inquest found last week.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27985078.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


89. More young women killed in alcohol-related car accidents. Nurs Stand; 2010 Mar 31;24(30):16

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Young men have greater representation in fatal alcohol-related accidents.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28029892.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


90. 'She was a tall, dark heart specialist...'. Nurs Stand; 2005 Jan 19;19(19):7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Romantic novel publishers Mills & Boon are appealing for nurses to become authors for its medical romance series of 'exciting, sensual love stories featuring confident, sensitive men and dedicated caring women'.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28006489.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


91. McCreaddie M: Little Britain makes our world a better place. Nurs Stand; 2005 Dec 07;20(13):39

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • He finds the TV series 'offensive' in its use of humour involving 'people in wheelchairs, working-class women and gay men'.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28001808.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


92. Osteoporitic fractures increase mortality risk for five to ten years. Nurs Stand; 2009 Jun 03;23(39):16-17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Low trauma fractures in older men and women are associated with increased mortality risk for five to ten years.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27996856.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


93. Students campaign against bar on bisexual and gay blood donors. Nurs Stand; 2006 Feb 22;20(24):11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : The National Union of Students (NUS) is urging its members to become blood donors to counteract the numbers lost because gay and bisexual men are not allowed to donate.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27977969.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


94. Horvath L, Zhao L, Lee B, Brown D, Molloy M, Marx G, Boyer M, Breit S, Sutherland R, Henshall S: Identification of candidate biomarkers of therapeutic response to docetaxel in hormone-refractory prostate cancer by proteomic profiling. J Clin Oncol; 2009 May 20;27(15_suppl):11010

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 11010 Background: Docetaxel (DTX)-based chemotherapy improves symptoms and survival in men with advanced hormone-refractory prostate cancer (HRPC).
  • Plasma/serum samples were collected from 41 men with metastatic HRPC treated with DTX-based chemotherapy (36 with paired samples pre- and post- cycle 1 DTX).
  • The association between MIC-1 levels, PSA response and overall survival (OS) were assessed by non-parametric tests and Kaplan-Meier survival analysis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963974.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


95. Christiansen CF, Johansen MB, Christensen S, Langeberg W, Fryzek JP, Toft Sørensen H: Incidence of acute kidney injury in cancer patients: A population-based cohort study in Denmark. J Clin Oncol; 2009 May 20;27(15_suppl):9570

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Therefore, we examined the incidence of AKI within the first year after cancer diagnosis to estimate the magnitude of this risk and better understand which patients are at greatest risk.
  • METHODS: Using the population-based Danish Cancer Registry, we conducted a retrospective cohort study of 4,427 men and women from North Jutland, Denmark (population 500,000) diagnosed with cancer from 2002 to 2003 (non-melanoma skin cancer excluded).
  • AKI was defined according to the Risk/ Injury/ Failure/ Loss/ End-stage-renal-disease (RIFLE) criteria.
  • Baseline sCr was defined as the lowest sCr in the year before cancer diagnosis.
  • We compared this value to the highest sCr on record during the first year following cancer diagnosis to identify those who experienced an AKI.
  • RESULTS: Median age for the cohort was 68.6 years, 50.9% were men, and the most common cancer sites were lung (14.2%), breast (13.7%), prostate (9.8%), colon (9.6%), rectum (5.1%), and bladder (6.3%).
  • Incidence was highest among patients aged 80 years or older (531 per 1,000 person-years, 95% CI 464-606) and in those with cancer of the liver (1,221, 95%CI 676-2,205), pancreas (1,472, 95%CI 1,130-1,917), or kidney (1,254, 95%CI 974-1,616), or with multiple myeloma (855, 95%CI 538-1,356).
  • Our study showed that over 20% of cancer patients may experience acute kidney injury in the first year after diagnosis.
  • Older patients and those with cancer of the liver, pancreas, or kidney, or with multiple myeloma are especially at risk for AKI.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963659.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


96. Schmidt K, Monahan P, Tong Y, Rawl S, Rand K, Cripe LD: Coping styles and psychological outcomes in men with advanced cancer. J Clin Oncol; 2009 May 20;27(15_suppl):e20521

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Coping styles and psychological outcomes in men with advanced cancer.
  • : e20521 Background: The psychological outcomes of men with advanced cancer may vary based upon their appraisal and response to the threat of cancer.
  • Coping styles in other illnesses are influenced by gender and stage of disease, but little is known specifically about men with advanced cancer.
  • METHODS: We recruited 81 men with advanced cancer to complete surveys assessing coping (Mini-MAC), post-traumatic growth (PTGI), and psychological outcomes (Hospital Anxiety and Depression Scale).
  • Fourteen men (17%) scored 8-10 and 8 (10%) scored ≥11 suggesting an anxiety state and disorder, respectively.
  • Eight men (10%) had scores suggesting a depressive state and 4 (5%) a depressive disorder.
  • In addition, greater fatalism was significantly associated with greater post-traumatic growth in all five areas assessed by the PTGI subscales (.27 < r < .36; .001 p < .032).
  • CONCLUSIONS: As expected men with advanced cancer report anxiety and depression.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961013.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Winkfield KM, Chen M, Dosoretz DE, Salenius SA, Katin MJ, Ross R, D'Amico AV: Race and survival following brachytherapy-based treatment for men with localized or locally advanced adenocarcinoma of the prostate. J Clin Oncol; 2009 May 20;27(15_suppl):5068

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Race and survival following brachytherapy-based treatment for men with localized or locally advanced adenocarcinoma of the prostate.
  • METHODS: The study cohort was comprised of 4,880 men with clinical stage T1-3N0M0 prostate cancer and minimum follow-up of 2 years who underwent brachytherapy-based treatment at 20 centers within the 21st Century Oncology consortium.
  • A Cox regression multivariable analysis was used to evaluate the risk of death in African-American (AA) and Hispanic (H) men as compared to Caucasian men adjusting for age, pretreatment PSA, Gleason score, clinical T stage, year and type of treatment, and comorbidity level.
  • CONCLUSIONS: African-American and Hispanic race as compared to white race appear to confer a higher risk of mortality following brachytherapy-based treatment in men with localized or locally advanced prostate cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964249.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


98. Wrong Place, Wrong Time - Trauma and Violence in the Lives of Young Black Men John A Rich Wrong Place, Wrong Time - Trauma and Violence in the Lives of Young Black Men Johns Hopkins University Press 212pp $24.95 /£13 978 0 8018 9363 6 0801893631 [Formula: see text]. Nurs Stand; 2010 Mar 31;24(30):30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Wrong Place, Wrong Time - Trauma and Violence in the Lives of Young Black Men John A Rich Wrong Place, Wrong Time - Trauma and Violence in the Lives of Young Black Men Johns Hopkins University Press 212pp $24.95 /£13 978 0 8018 9363 6 0801893631 [Formula: see text].
  • He dissects with powerful reality the sad, destructive and mindless cycle of violence among young black men.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28029869.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


99. The quality of older people's relationships may reduce disability. Nurs Stand; 2010 Jun 23;24(42):17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Older men who live alone could alleviate the risk of disability onset by becoming socially active.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28019488.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


100. Newnham D: OutsideIn. Nurs Stand; 2009 May 27;23(38):26-27

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : My neighbour Gerald was philosophical about his diagnosis.
  • 'The doctor says more men die with prostate cancer than of it,' he told me.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27996769.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down






Advertisement